RHYTHM PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Stock Issued During Period, Shares, New Issues of 580.00 thousand shares as of 2022-10-18, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-02-26
- 2022-10-18: Stock Issued During Period, Shares, New Issues 580.00K shares.
- 2022-09-19: Stock Issued During Period, Shares, New Issues 4.80M shares.
- 2021-02-28: Stock Issued During Period, Shares, New Issues 1 month 5.75M shares.
- 2021-02-21: Stock Issued During Period, Shares, New Issues 5.75M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2022-10-18 | 580.00K shares 10-K · filed 2026-02-26 | |
| 2022-09-19 | 4.80M shares 10-K · filed 2026-02-26 | |
| 2021-02-28 | 5.75M shares 10-K · filed 2022-03-01 | |
| 2021-02-21 | 5.75M shares 10-K · filed 2022-03-01 | |
| 2021-02-09 | 5.75M shares 10-K · filed 2025-02-28 | |
| 2019-10-18 | 9.32M shares 10-K · filed 2022-03-01 | |
| 2018-10-18 | 9.32M shares 10-K · filed 2020-03-02 | |
| 2018-06-25 | 6.59M shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |